MyFinsight
Home
Blog
About
Contact
Download
Download image
Vendor advances, gross
$3,271K
Intangible assets, net
$102K
Deferred offering costs
$1,308K
Prepaid expenses and
other current assets
$24K
Vendor advances, net
$1,057K
Cash and cash
equivalents
$5,575K
Less accumulated
amortization
$2,214K
Total other assets
$1,410K
Total current assets
$6,656K
Total assets
$8,066K
Total liabilities and
shareholders equity
$8,066K
Total shareholders
equity
$7,664K
Total current
liabilities
$402K
Accumulated deficit
-$12,897K
Additional paid-in capital
$20,540K
Accounts payable and
accrued expenses
$402K
Common stock, par value
0.001, 100,000,000...
$21K
Back
Back
Balance Sheet
source: myfinsight.com
Kairos Pharma, LTD. (KAPA)
Kairos Pharma, LTD. (KAPA)